Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.

Obón-Santacana M, Lujan-Barroso L, Travis RC, Freisling H, Ferrari P, Severi G, Baglietto L, Boutron-Ruault MC, Fortner RT, Ose J, Boeing H, Menéndez V, Sánchez-Cantalejo E, Chamosa S, Castaño JM, Ardanaz E, Khaw KT, Wareham N, Merritt MA, Gunter MJ, Trichopoulou A, Papatesta EM, Klinaki E, Saieva C, Tagliabue G, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Onland-Moret NC, Idahl A, Lundin E, Weiderpass E, Vesper HW, Riboli E, Duell EJ.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):127-34. doi: 10.1158/1055-9965.EPI-15-0822. Epub 2015 Nov 23.

2.

Acrylamide and glycidamide hemoglobin adduct levels and endometrial cancer risk: A nested case-control study in nonsmoking postmenopausal women from the EPIC cohort.

Obón-Santacana M, Freisling H, Peeters PH, Lujan-Barroso L, Ferrari P, Boutron-Ruault MC, Mesrine S, Baglietto L, Turzanski-Fortner R, Katzke VA, Boeing H, Quirós JR, Molina-Portillo E, Larrañaga N, Chirlaque MD, Barricarte A, Khaw KT, Wareham N, Travis RC, Merritt MA, Gunter MJ, Trichopoulou A, Lagiou P, Naska A, Palli D, Sieri S, Tumino R, Fiano V, Galassom R, Bueno-de-Mesquita HB, Onland-Moret NC, Idahl A, Lundin E, Weiderpass E, Vesper H, Riboli E, Duell EJ.

Int J Cancer. 2016 Mar 1;138(5):1129-38. doi: 10.1002/ijc.29853. Epub 2015 Oct 1.

3.

Dietary and lifestyle determinants of acrylamide and glycidamide hemoglobin adducts in non-smoking postmenopausal women from the EPIC cohort.

Obón-Santacana M, Lujan-Barroso L, Freisling H, Cadeau C, Fagherazzi G, Boutron-Ruault MC, Kaaks R, Fortner RT, Boeing H, Ramón Quirós J, Molina-Montes E, Chamosa S, Castaño JM, Ardanaz E, Khaw KT, Wareham N, Key T, Trichopoulou A, Lagiou P, Naska A, Palli D, Grioni S, Tumino R, Vineis P, De Magistris MS, Bueno-de-Mesquita HB, Peeters PH, Wennberg M, Bergdahl IA, Vesper H, Riboli E, Duell EJ.

Eur J Nutr. 2017 Apr;56(3):1157-1168. doi: 10.1007/s00394-016-1165-5. Epub 2016 Feb 5.

4.

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.

Ose J, Schock H, Tjønneland A, Hansen L, Overvad K, Dossus L, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopolou A, Benetou V, Lagiou P, Masala G, Tagliabue G, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Onland-Moret NC, Weiderpass E, Gram IT, Sánchez S, Obon-Santacana M, Sànchez-Pérez MJ, Larrañaga N, Castaño JM, Ardanaz E, Brändstedt J, Lundin E, Idahl A, Travis RC, Khaw KT, Rinaldi S, Romieu I, Merritt MA, Gunter MJ, Riboli E, Kaaks R, Fortner RT.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):951-61. doi: 10.1158/1055-9965.EPI-14-1279-T. Epub 2015 Apr 8.

5.

Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.

Obón-Santacana M, Peeters PH, Freisling H, Dossus L, Clavel-Chapelon F, Baglietto L, Schock H, Fortner RT, Boeing H, Tjønneland A, Olsen A, Overvad K, Menéndez V, Sanchez MJ, Larrañaga N, Huerta Castaño JM, Barricarte A, Khaw KT, Wareham N, Travis RC, Merritt MA, Trichopoulou A, Trichopoulos D, Orfanos P, Masala G, Sieri S, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, Onland-Moret NC, Wirfält E, Stocks T, Idahl A, Lundin E, Skeie G, Gram IT, Weiderpass E, Riboli E, Duell EJ.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):291-7. doi: 10.1158/1055-9965.EPI-14-0636. Epub 2014 Oct 9.

6.

Associations of hemoglobin biomarker levels of acrylamide and all-cause and cardiovascular disease mortality among U.S. adults: National Health and Nutrition Examination Survey 2003-2006.

Huang M, Jiao J, Wang J, Chen X, Zhang Y.

Environ Pollut. 2018 Jul;238:852-858. doi: 10.1016/j.envpol.2018.03.109. Epub 2018 Apr 6.

PMID:
29627755
7.

Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.

Schock H, Surcel HM, Zeleniuch-Jacquotte A, Grankvist K, Lakso HÅ, Fortner RT, Kaaks R, Pukkala E, Lehtinen M, Toniolo P, Lundin E.

Endocr Relat Cancer. 2014;21(6):831-44. doi: 10.1530/ERC-14-0282.

8.

Epithelial Ovarian Cancer with Endometriosis is not Associated with Menopausal Status: a Co-Association Study at Prapokklao Hospital

Muangtan S, Suknikhom W, Sananpanichkul P, Bhamarapravatana K, Suwannarurk K.

Asian Pac J Cancer Prev. 2018 May 26;19(5):1337-1341.

9.

Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.

Vesper HW, Slimani N, Hallmans G, Tjønneland A, Agudo A, Benetou V, Bingham S, Boeing H, Boutron-Ruault MC, Bueno-de-Mesquita HB, Chirlaque D, Clavel-Chapelon F, Crowe F, Drogan D, Ferrari P, Johansson I, Kaaks R, Linseisen J, Lund E, Manjer J, Mattiello A, Palli D, Peeters PH, Rinaldi S, Skeie G, Trichopoulou A, Vineis P, Wirfält E, Overvad K, Strömberg U.

J Agric Food Chem. 2008 Aug 13;56(15):6046-53. doi: 10.1021/jf703750t. Epub 2008 Jul 15.

PMID:
18624432
10.

Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004.

Vesper HW, Caudill SP, Osterloh JD, Meyers T, Scott D, Myers GL.

Environ Health Perspect. 2010 Feb;118(2):278-83. doi: 10.1289/ehp.0901021.

11.

Relationships between acrylamide and glycidamide hemoglobin adduct levels and allergy-related outcomes in general US population, NHANES 2005-2006.

Guo J, Yu D, Lv N, Bai R, Xu C, Chen G, Cao W.

Environ Pollut. 2017 Jun;225:506-513. doi: 10.1016/j.envpol.2017.03.016. Epub 2017 Mar 18.

PMID:
28325597
12.

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR.

J Natl Cancer Inst. 2002 Apr 3;94(7):497-504.

PMID:
11929950
13.

Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study.

Xie J, Terry KL, Poole EM, Wilson KM, Rosner BA, Willett WC, Vesper HW, Tworoger SS.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):653-60. doi: 10.1158/1055-9965.EPI-12-1387. Epub 2013 Feb 15.

14.

Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.

Gram IT, Lukanova A, Brill I, Braaten T, Lund E, Lundin E, Overvad K, Tjønneland A, Clavel-Chapelon F, Chabbert-Buffet N, Bamia C, Trichopoulou A, Zylis D, Masala G, Berrino F, Galasso R, Tumino R, Sacerdote C, Gavrilyuk O, Kristiansen S, Rodríguez L, Bonet C, Huerta JM, Barricarte A, Sánchez MJ, Dorronsoro M, Jirström K, Almquist M, Idahl A, Bueno-de-Mesquita HB, Braem M, Onland-Moret C, Tsilidis KK, Allen NE, Fedirko V, Riboli E, Kaaks R.

Int J Cancer. 2012 May 1;130(9):2204-10. doi: 10.1002/ijc.26235. Epub 2011 Sep 14.

15.

Association of acrylamide hemoglobin biomarkers with obesity, abdominal obesity and overweight in general US population: NHANES 2003-2006.

Huang M, Zhuang P, Jiao J, Wang J, Zhang Y.

Sci Total Environ. 2018 Aug 1;631-632:589-596. doi: 10.1016/j.scitotenv.2018.02.338. Epub 2018 Mar 16.

PMID:
29533795
16.

Exposure to acrylamide and the risk of cardiovascular diseases in the National Health and Nutrition Examination Survey 2003-2006.

Zhang Y, Huang M, Zhuang P, Jiao J, Chen X, Wang J, Wu Y.

Environ Int. 2018 Aug;117:154-163. doi: 10.1016/j.envint.2018.04.047. Epub 2018 May 9.

PMID:
29753146
17.

Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.

Zhang Y, Hua W, Niu LC, Li SM, Wang YM, Shang L, Zhang C, Li WN, Wang R, Chen BL, Xin XY, Zhang YQ, Wang J.

Tumour Biol. 2016 Jul;37(7):9423-31. doi: 10.1007/s13277-015-4699-x. Epub 2016 Jan 18. Erratum in: Tumour Biol. 2016 Jun;37(6):8465.

PMID:
26781874
18.

Circulating prolactin levels and risk of epithelial ovarian cancer.

Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, Shore RE, Sieri S, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2013 Apr;24(4):741-8. doi: 10.1007/s10552-013-0156-6. Epub 2013 Feb 3.

19.

CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.

Liu P, Sun YL, Du J, Hou XS, Meng H.

Int J Gynecol Cancer. 2012 May;22(4):586-92. doi: 10.1097/IGC.0b013e31823c36b8.

PMID:
22266931
20.

Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.

Ose J, Fortner RT, Rinaldi S, Schock H, Overvad K, Tjonneland A, Hansen L, Dossus L, Fournier A, Baglietto L, Romieu I, Kuhn E, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Masala G, Sieri S, Tumino R, Sacerdote C, Mattiello A, Ramon Quiros J, Obón-Santacana M, Larrañaga N, Chirlaque MD, Sánchez MJ, Barricarte A, Peeters PH, Bueno-de-Mesquita HB, Onland-Moret NC, Brändstedt J, Lundin E, Idahl A, Weiderpass E, Gram IT, Lund E, Kaw KT, Travis RC, Merritt MA, Gunther MJ, Riboli E, Kaaks R.

Int J Cancer. 2015 Jan 15;136(2):399-410. doi: 10.1002/ijc.29000. Epub 2014 Jun 16.

Supplemental Content

Support Center